Screener/Healthcare/Biotechnology

TVTX

Travere Therapeutics, Inc.NASDAQ
$26.86-0.90 (-3.24%)
Mid CapUnder $50HealthcareFastest Growing
$12.91
$42.13
$26.48
$27.34
EPS (TTM)$-0.30
P/E Ratio—
Dividend Yield—
Market Cap$2.66B
Volume497K
Prev Close$27.75
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$129.7M$2.7M$0.0398.0%2.1%
Q3 '25$164.9M$25.7M$0.2899.0%15.6%
Q2 '25$114.4M-$12.8M$-0.1498.7%-11.1%
Q1 '25$81.7M-$41.2M$-0.4794.3%-50.4%
Q3 '24$62.9M-$54.8M$-0.7097.4%-87.1%
Q2 '24$54.1M-$70.4M$-0.9196.2%-130.1%
Q1 '24$41.4M-$136.1M$-1.7696.4%-328.9%
Q4 '23$45.1M-$90.2M$-1.1889.9%-200.1%
Get Your Daily Market Recap